David Platt
2010
In 2010, David Platt earned a total compensation of $153.6K as Chief Executive Officer at Galectin Therapeutics, a 19% decrease compared to previous year.
Compensation breakdown
| Other | $153,602 |
|---|---|
| Total | $153,602 |
Platt received $153.6K in other compensation, accounting for 100% of the total pay in 2010.
Rankings
In 2010, David Platt's compensation ranked 10,105th out of 10,439 executives tracked by ExecPay. In other words, Platt earned more than 3.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,105 out of 10,439 | 3rd |
Division Manufacturing | 3,722 out of 3,838 | 3rd |
Major group Chemicals And Allied Products | 892 out of 921 | 3rd |
Industry group Drugs | 659 out of 680 | 3rd |
Industry Pharmaceutical Preparations | 467 out of 481 | 3rd |
Source: SEC filing on April 11, 2011.
Platt's colleagues
We found five more compensation records of executives who worked with David Platt at Galectin Therapeutics in 2010.
2010
Theodore Zucconi
Galectin Therapeutics
Chief Executive Officer
2010
Anatole Klyosov
Galectin Therapeutics
Chief Scientist
2010
Anthony Squeglia
Galectin Therapeutics
Chief Financial Officer
2010
Maureen Foley
Galectin Therapeutics
Chief Operating Officer
2010
Eliezer Zomer
Galectin Therapeutics